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Abstract
Mucopolysaccharidosis type I (MPS I) was a group of rare autosomal recessive disorder caused by the deficiency of
the lysosomal enzyme, alpha -L -iduronidase, and the resulting accumulation of undergraded dematan sulfate and
heparan sulfate. MPS I patients have a wide range of clinical presentations, that makes it difficult to predict patient
phenotype which is needed for genetic counseling and also impedes the selection and evaluation of patients
undergoing therapy bone marrow transplantation.
Aim of the study: consanguinity rates have been determined among 14 families with mucopolysaccharidosis type
I, seen in the pediatric departments of different geographic areas of Tunisia (Central and Southern areas) for the
period August 2004 - August 2011 in order to investigate the relation between consanguinity and this disorder.
Patients and methods: Clinical and molecular analyses confirmed the diagnosis for MPS type I in the studied
families.
Results: Most of the Tunisian MPS I patients have been identified at the homozygous status: p.P533R mutation (7
homozygous and one double heterozygous p.L578Q/p.P533R patients; 41.66% of all the investigated MPSI patients),
p.F177S (1 homozygous patient; 5.55%), p.L530fs (1 patient; 5.55%), p.Y581X (2 patients; 11.11%), p.F602X (3
patients; 16.66%), p.R628X (1 patient; 5.55%). Another mutation: p.L578Q has been identified at the heterozygous
status in the only double heterozygous p.L578Q/p.P533R case. Part of the mutations was the result of a founder
effect. These described points are the consequences of the high rate of consanguinity.
Conclusion: The high frequency of p.P533R mutation could be explained by the high degree of inbreeding. This is
due to the richness of the genetic background of the studied population.
A multidisciplinary approach is essential to develop adequate preventive program adapted to the social, cultural,
and economic context.
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Background
Mucopolysaccharidoses (MPS) are a group of lysosomal
storage and inherited disorders caused by the deficiency
of specific enzymes which leads to the lysosomal accu-
mulation of glycosaminoglycanes. Mucopolysaccharido-
s i st y p eIi sc a u s e db yad e f i c i e n c yo ft h eg l y c o s i d a s e
alpha-L-iduronidase (a-L-iduronidase iduronohydrolase,
EC 3.2.1.76; IDUA) and the resulting accumulation of
undergraded dermatan sulfate and heparan sulfate [1].
Accumulation of partially degraded of this macromole-
cules leads to typical symptoms of lysosomal storage
disorder. Clinical phenotypes may vary considerably so
that 3 different forms, severe (MPS IH, Hurler), mild
(MPS IS, Scheie), and intermediate (MPS IH/S, Hurler/
Scheie) are individualized.
The most severe form as well as the most common
and the best known of the Hurler syndrome is charac-
terized by retardation of physical and mental develop-
ment, cornea clouding, dysostosis multiplex, joint
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blems, and death in childhood. The mildest form
(Scheie syndrome), is compatible with normal intelli-
gence, stature and lifespan; this form of disease pro-
gresses slowly with cloudy corneas, joint stiffness and
aortic valve disease as the major problems. The inter-
mediate form (Hurler/Scheie syndrome) is characterized
by normal intelligence with physical manifestations
intermediate between Hurler and Scheie syndromes.
Survival commonly occurs at early adulthood.
Tunisia is one of the North African countries, geogra-
phically situated in a central position at the crossroad
between Africa and Europe. The demographic features
of the Tunisian population include among others high
rates of consanguinity.
Consanguineous marriages are associated with a
higher frequency of autosomal recessive disorders and
more precisely between first cousins [2]. This rule
r e s u l t sf r o mp a r t i c u l a rt r a d i t i o n sa sac o n s e q u e n c eo f
cultural and economical reasons.
In addition, Arab countries including Tunisia are
known to present a high number of mothers over 35
years of age, a large family size, a high frequency of
hemoglobinopathies [3] and Cystic fibrosis [4]. Consan-
guinity still continues to attract attention among medi-
cal and population geneticists, clinicians and scientists.
Thus, an association between parental consanguinity
and the frequency of MPS IH will be reported and
discussed.
Patients and methods
We report here on the spectrum of MPS IH diseases in
Tunisia. The study was carried out on 14 MPS I families
recruited in Pediatric departments of different geo-
graphic areas of Tunisia (Central and Southern areas).
The phenotypic and molecular diagnoses were con-
firmed in our laboratory of Biochemistry at the Farhat
Hached Hospital of Sousse in Tunisia. This actual study
followed the previous work which already included 6
MPS I families (family A to family F) (Figure 1).
Familial questionnaire
Tunisia is one of the Muslim North African countries,
geographically situated in a central position at the cross-
road between Africa and Europe. The estimated popula-
tion in July 2011 is 10,629,186 inhabitants with a
population growth rate of 0.978% (http://www.index-
mundi.com/fr/tunisie/population_profil.html).N e a r l ya l l
the Tunisians are Muslims (98% of the population) the
others are Jewish, Christians. Consanguinity rates were
studied among 14 families with mucopolysaccharidosis
type I, seen in the Pediatric departments of different
geographic areas of Tunisia (Central and Southern
areas) for the period August 2004 to August 2011. All
the patients are offspring of consanguineous marriages
between first, second or third cousins (Figure 1 and
Table 1).
The families of MPS I patients have been questioned
to establish an inventory of the consanguineous unions
and to determine the relation between consanguinity
and the frequency of MPS I Tunisia. Each studied family
accepted our preliminary family inquiry on one hand
about for their awareness of the seriousness of the dis-
ease and on the other hand, about the intensity of their
commitment to hope to find a cure for this disease.
This study was approved by the Ethics committees of
the Tunisian hospitals, and all families gave informed
consent
Results
The biological, enzymatic and molecular analyses con-
firmed the MPS diagnosis for all the studied patients.
The clinical characteristics of MPS I patients have been
reported below (Table 1).
No major mutations appear to be specific to our
country and there is a tremendous heterogeneity in the
mutation spectrum. No mutation represents more than
53% of the Tunisian MPS I alleles and in approximately
3% of the alleles the mutations are novel or very rare.
Therefore, rarely in one case the genotype of the patient
shows a unique combination of mutation (Table 2).
Patients of family A
This boy of 11 years was symptomatic when MPS has
been detected in the hospital of Sousse by biological
assay with very high urinary excretion of glycosamino-
glycans (136 mg/g of creatinine) (usual values: 6-23) and
abnormal electrophoresis profile (dermatan sulfate and
heparan sulfate). MPS I was confirmed by enzymatic
assay with a very low IDUA activity (0.1 nmol/h/mg)
(usual values: 1-5). He presented psychomotor retarda-
tion: he walked at the age of 1 and 6 months and he
speaked at the age of 2 years. His clinical features
included coarse facial features, hydrocephalus, hepatos-
plenomegaly. He developed enlarged tongue, thick lips,
bushy eyebrows, exophtalmos, noisy breathing and hear-
ing loss. He had, at 10 years and 10 months, 114 cm (-4
S.D.) of height and 28 kg (-1 S.D.) of weight.
Patients of family B
At the age of 1 year and 4 months, the boy was referred
t oP e d i a t r i cU n i ta tD j e r b aI s l a n dH o s p i t a lf o rt h r e e
days. He developed macrocephaly, hepatosplenomegaly,
psychomotor retardation with especially language pro-
blems. At admission, the examination highlighted short
neck and trunck, spacing and shape teeth, enlarged ton-
sils, enlarged tongue and thick lips. At the age of three
years, he had 98 cm (+2 S.D.) of height and 18 kg (+3 S.
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Page 2 of 7D.) of weight.. The biochemical assay showed very high
urinary excretion of glycosaminoglycans (120 mg/g of
creatinine) (usual values: 9-46) and abnormal electro-
phoresis profile with dermatan sulfate and heparan sul-
fate. MPS I was confirmed by enzymatic assay with a
very low IDUA activity (0.08 nmol/h/mg) (usual values:
1-5). This patient (3 years old) whose parents were sec-
ond cousin, had a family history with three maternal
cousins: one of them (13 years old) was followed for
convulsing encephalopathy and infirmity matrix, the
other cousin (3 years old) was followed in the same
Pediatric Unit for encephalopathy.
Patient of family C
This little boy was the first child of first cousin parents.
The boy was referred to Pediatric Unit at Bizerte Hospi-
tal. At the age of 1 year and 8 months, he had 79 cm
(-2 S.D.) of height and 10 kg (+4 S.D.) of weight and he
      
       
Figure 1 Pedigrees of the six investigated MPS I Tunisian families. Squares and circles indicate male and female members, respectively.
Double lines indicate consanguineous matings. The virtual slide for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/
vs/1863141266606652/1.
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Page 3 of 7developed psychomotor retardation with abnormal flex-
ibility of joints, facial dysmorphisms with coarse features
and dystrophia of cornea. The biological assay showed
very high urinary excretion of glycosaminoglycans (116
mg/g of creatinine) (usual values: 9-46) and abnormal
electrophoresis profile with dermatan sulfate and
heparan sulfate. MPS I was confirmed by enzymatic
assay with a very low IDUA activity (0.1 nmol/h/mg)
(usual values: 1-5). He deceased at the age of two years.
Patient of family D
This girl, whose parents were first cousin, was diagnosed
a tt h ea g eo f2m o n t h sa n d5d a y s .S h ew a sr e f e r r e dt o
Pediatric Unit at La Rabta Hospital. She was evaluated
for dyspnea and laryngeal crisis. At the age of 14
months she presented facial dysmorphisms. At the age
of 3 years and 6 months she had 90 cm (+3 S.D.) of
height and 15 kg (+3.5 S.D.) of weight. At the age of 10
years she had 95 cm (-5 S.D.) of height and 18 kg (-2 S.
D.) of weight.. The biological assay showed very high
urinary excretion of glycosaminoglycans (97 mg/g of
creatinine) (usual values: 9-46) and abnormal electro-
phoresis profile with dermatan sulfate and heparan sul-
fate. MPS I was confirmed by enzymatic assay with a very
low IDUA activity (0.1 nmol/h/mg) (usual values: 1-5)
MPS I was confirmed by enzymatic assay with a very low
IDUA activity (0.0 nmol/h/mg) (usual values: 1-5).
Table 1 consanguinity profile and genotypes characteristics of MPS I Tunisians patients
MPS I
families
age of parents at
birth
relationship
(affected/unaffected siblings)
origin Consanguinity Mutations MPS I
subtype
references
1 38 years (M), 40
years (F)
3/0 Sfax (South) 3
rd degree p.F602XH Hurler [11]
2 55 years (M), 65
years (F)
2/2 Gabes (South) 1
st degree p.P533RH Hurler [11]
3 40 years (M), 49
years (F)
2/2 Djerba Island
(South)
2
rd degree p.P533RH Hurler/
Scheie
[11]
4 34 years (M), 40
years (F)
1/3 Tunis (North) 1
st degree p.P533RH Hurler/
Scheie
[11]
5 50 years (M), 62
years (F)
1/6 Mahdia (Center) 1
st degree p.R628XH Hurler [11]
6 42 years (M), 50
years (F)
1/3 Sousse (Center) 1
st degree p.P533RH Hurler [11]
7 37 years (M), 44
years (F)
1/6 Djerba Island
(South)
2
rd degree p.L578Q/p.
P533R
Scheie [11]
8 38 years (M),
46years (F)
1/1 Makther 2
rd degree p.Y581XH Hurler [11]
A 42 years (M), 46
years (F)
1/3 Sfax (sud) 3
rd degree p.P533RH Scheie [12]
B 41 years (M), 41
years (F)
1/6 Djerba Island
(South)
2
rd degree p.P533RH Hurler [12]
C 37 years (M), 44
years (F)
1/0 Bizerte (North) 1
st degree p.L530fsH Hurler [12]
D 39 years (M), 39
years (F)
1/2 Tunis (North) 1
st degree p.Y581XH Hurler [12]
E 38 years (M),
42years (F)
1/2 Tunis (North) 1
st degree p.F177SH Hurler [12]
F 42 years (M), 46
years (F)
1/7 Djerba Island
(South)
2
rd degree p.P533RH Hurler [12]
M: Mother
F: Father
H: homozygous status
Table 2 Mutation frequencies in the MPS I Tunisian
patients investigated [2004-2011]
Type of the
MPS I
Mutation
Number of the MPS I allele
for the considered
mutation/Total of Tunisian
MPS I allele
Percentage of the MPS I
allele of the considered
mutation
p.P533R 15/28 53.57
p.R628X 2/28 7.14
p.F602X 2/28 7.14
p.Y581X 4/28 14.28
p.L530fs 2/28 7.14
p.F177S 2/28 7.14
p.L578Q 1/28 3.57
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The 2 years girl has been followed up since the age of
18 months for MPS. She was referred to Pediatric Unit
at La Rabta Hospital. MPS I was confirmed by enzy-
matic assay with a very low IDUA activity (0.5 nmol/h/
mg) (usual values: 1-5 nmol/h/mg). Gradually, she
developed facial dysmorphisms, scaphocephaly, skeletal
dysplasia, spacing and shape teeth, enlarged tonsils,
thick lips, bushy eyebrows, umbilical hernia, mitral valve
regurgitation and coax valga. She had also hepatospleno-
megaly and cardiomegaly. Cervical MRI indicated com-
pression of the medulla. At the age of 4 years she had
103 cm (-2.7 S.D.) of height and 18 kg (+2 S.D.) of
weight.. The biochemical analysis showed very high
urinary excretion of glycosaminoglycans (125 mg/g of
creatinine) (usual values: 9-46) and abnormal electro-
phoresis profile with dermatan sulfate and heparan sul-
fate. MPS I was confirmed by enzymatic assay with a
very low IDUA activity (0.1 nmol/h/mg) (usual values:
1-5). The overall physical handicap was severe and she
died at the age of 11 years. In 2005, this family benefited
from a prenatal diagnosis showing a normal enzymatic
activity (3.5 nmol/h/mg) (usual values: 1-5).
Patient of family F
He was the last child born in this consanguineous family
after 7 MPS I unaffected brothers. By the age of 1 year,
the boy was referred to Pediatric unit of Djerba Island
(south of Tunisia). He was evaluated for hepatospleno-
megaly, splenomegaly, and facial dysmorphism. At the
age of 2 years he had 78 cm (-2 S.D.) of height and 11
kg (-1 S.D.) of weight. The biological assay showed very
high urinary excretion of glycosaminoglycans (102 mg/g
of creatinine) (usual values: 9-46), abnormal electro-
phoresis profile with dermatan sulfate and heparan sul-
fate and very low IDUA activity (0.1 nmol/h/mg) (usual
values: 1-5).
He is presently hospitalized in the Transplant Center
Unit in Tunis (North Tunisia) for bone marrow trans-
plantation. In three months, we will expect a post trans-
plant and we will control the IDUA activity.
Discussion
In Tunisia, prevalences of different types of mucopoly-
saccharidoses have been evaluated: MPS global inci-
dence was evaluated at 2.3/100.000 lives births in 2001
[5]. Although the covering data was the widest possible,
the prevalence of the MPS were undervalued and under-
appreciated due to ignorance of some clinical pictures
by clinicians of the Tunisian public health. A national
retrospective study covering the period 1970 - 2005 con-
cerning the incidence of mucopolysaccharidoses in
Tunisia, showed that prevalence of the MPS I (Hurler,
Hurler/Scheie and Scheie forms), MPS III (Sanfilippo)
and MPS IVA (Morquio) was estimated at 0.63, 0.7 and
0.45 for 100,000 lives births respectively [6].
MPS I is the most common mucopolysaccharidosis
worldwide, with an average incidence of about 1.7 in
100.000 live births for the severe and mild forms [7].
The incidence of MPS I in Tunisia is also high, esti-
mated at 0.63 in 100.000 live births [6], explained by the
high rate of consanguinity.
Indeed, Tunisian population is characterized by the
large family size, high maternal and paternal age [2] and
a particularity high level of inbreeding with consangui-
nity rates in the range of 32-60% (all disconcerted
degree), according to a traditional practice followed the
same tribe, will age or social unit [8]. These high con-
sanguinity rates lead to the emergence of autosomal
recessive disease at high frequencies; L Romdhane and
al. described 346 genetics disorders identified in Tuni-
sian population. Among these, 62.9% are autosomal
recessive in which MPS I are included [2] also in Mor-
occan population [9].
In fact, all affected patients studied here are offspring
of consanguineous marriages between first degree cou-
sins in families 2, 4, 5, 6, C, D and E, second cousins in
families 3, 7, 8, B and F and third cousins twice
removed in families 1 and A (Table 1). This social fact
may explain the high frequency of MPS I detection in
Tunisian population.
Our molecular study [8,10-12] covering the period
2004 - 2011 showed that the most common MPS I
mutation in our country are P533R which represent
53.57% of all mutated MPS I alleles found in this cases
study. These data are consistent with the previous Tuni-
sian study where three novel mutations were found
[11,12]. Tunisia has different MPS I mutations frequen-
cies (Table 2) compared to those of other European
countries. We found that 53.57% (15/28) mutated alleles
carried the p.P533R mutation, 52.57% of them in a
homozygosity status and 1% in a heterozygosity status.
Such a high prevalence of this mutation has already
been described in the Maghrebian population such as in
Morocco (92%) in Tunisia and also in the Maghrebian
immigrant population in France [13,14]. In Europe, this
mutation has only been found among Italian patients
with the frequency of 11% [15].
We actually discovered that the three affected families
(families 3, B and F) have a parental relationship (Figure
1), suggesting that these families possibly originated
from a common ancestor. Both traditional and social
concerns such as geographical proximities, similar
instruction level, lead the couples to behave in a collec-
tive model, whatever conscious degree they have about
the consequences.
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have been frequently reported in studies from all over
the world such as in Japan and Australia; however the
impact of inbreeding in the incidence of these types of
disorders has not been described despite of the impor-
tant rate of consanguinity in some isolated communities
such as in Hirado in Japan (14.7%) [16] or in immigrant
ethnic groups, e.g., Lebanese in Australia (35.8%) [17].
An association between consanguinity and the MPS I
and IVA, especially in Tunisia, is suggested according to
general consanguineous data in addition to our specific
Tunisian experience in MPS I and MPS IVA (pedigrees,
inbreeding coefficients) [18].
It should be noted that there is a close relationship
between inbreeding and not only concerning the high
incidence of certain molecular lesions and their founder
effect but also the appearance of new mutations e.g., p.
F177S, p.L530fs and p.L578Q.
Associations between a specific mutation and a speci-
fic haplotype has been already demonstrated in genetic
disorders [18] and revealed that the specific mutation
was on a common background which suggests that
these mutant alleles were “identical by descent” and
were derived from a common ancestor.
Furthermore, the Tunisian population is also charac-
terized by its heterogeneity in its genetic structure
resulting from the mixing with other human groups
from the history by invasions and migrations [3]. A
large spectrum of mutations leading to some disorders
such as hemoglobinopathies especially beta-thalassemia
is identified as a result of rare alleles selection [3].
In fact, inbreeding increases the frequency of homozy-
gotes in the population and hence the risk of suffering
morbid. According to several studies, this behavior
appears to be closely linked to socio-economic and cul-
tural populations. Arab-Muslim populations are more
affected by this practice than others. In Arab societies,
all categories of cousins are getting married [2,13,14,16].
Studies of Arab and Islamic families show that inbreed-
ing is still a common feature of the system of alliances
still contracted in many countries i.e. Jordonia, Palestine,
Syria, Iraq, Kuwait, Saudi Arabia, Kurdistan, Iran, Paki-
stan, Egypt, Sudan, North Africa (e.g. Tunisia) and Leba-
non [19-21].
MPS present a social and economic impact at familial
and also national level since these diseases (all types
taken together and also MPS I separately) are still not
r a r ei no u ra r e aa n dt h e r ei sn oe f f e c t i v et h e r a p e u t i c
means, until now. This situation justifies the need and
importance of prenatal diagnosis. Two families (1 and
E) received a prenatal diagnosis [22] and one patient
(family F) had given bone marrow transplantation with
succeed.
Conclusion
The identification of mutations in MPS I families in
Tunisia permits genetic counseling of at-risk relatives,
and should facilitate molecular prenatal diagnosis in
Tunisians families which are particularly large. Consan-
guinity is common in the Arab world and particularly in
the Middle East which is largely inhabited by Arab and
Muslims. The level of inbreeding is high partially due to
the lack of awareness and commitment of individuals to
their traditional cultural values. The high frequency of
consanguineous marriages in patients with autosomal
recessive disorder (e.g. MPS I) is still very important,
increasing the incidence of certain lesions such as mole-
cular p.P533R mutation, in MPS I homozygous or dou-
ble heterozygous patients in Tunisia and Morocco. A
multidisciplinary preventive program e.g.: public educa-
tion or teaching of medical schools is needed to alert
the population.
Consent
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Abbreviations
MPS: Mucopolysaccharidoes; MPS I: Mucopolysaccharidosis type I; MPS IH:
Hurler syndrome; IDUA: Alpha L iduronidase; MPS IVA:
mucopolysaccharidosis type IVA; GALNS: N-acetylgalactosamine-6-sulfate-
sulfatase; SD: standard deviation. DPN: prenatal diagnosis.
Acknowledgements
We grateful acknowledge the patients and their families for participation in
this study. We thank Dr. R. Foroissart and Dr. C. Vianey-Saban for helpful
contributions.
Author details
1Laboratory of Biochemistry Farhat Hached Hospital 4000 Sousse - Tunisia.
2Laboratory of Molecular Biology University of Pharmacy 5000 Monastir -
Tunisia.
3Laboratory of Pediatric La Rabta Hospital Tunis-Tunisia.
Authors’ contributions
LC and SL: wrote the manuscript. LC and SK perfromed all the work (PCR,
sequencing...) in the laboratory. HC, HB and MFB participated in data
analysis. SF, SL and AM revised the manuscript and save final approval of
the version to be published. All authors read and approved the final
manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 16 September 2011 Accepted: 10 November 2011
Published: 10 November 2011
References
1. Neufeld EF, Muenzer J: The mucopolysaccharidoses. In The Metabolic and
Molecular Bases of Inherited Disease.. 8 edition. Edited by: Scriver CR,
Beaudet AL, Sly WS, Valle D. McGraw-Hill, New York; 2002:2421-3452.
2. Romdhane L, Abdelhak S: Genetic diseases in the Tunisian population.
Am J Med Genet A 2011, 155:238-67.
Chkioua et al. Diagnostic Pathology 2011, 6:113
http://www.diagnosticpathology.org/content/6/1/113
Page 6 of 73. Haj Khelil A, Laradi S, Miled A, Tadmouri GO, Ben Chibani J, Perrin P:
Clinical and molecular aspects of hemoglobinopathies in Tunisia. Clin
Chim Acta 2004, 340:127137.
4. Messaoud T, Bel Haj Fredj S, Bibi A, Elion J, Férec C, Fattoum S: Molecular
epidemiology of cystic fibrosis in Tunisia. Ann Biol Clin 2005, 63:627-630.
5. Laradi S, Monastiri K, Ferchichi S, Nabli N, Aouini Rea P, Ben Limam H, Ben
Mansour R, Bousoffara R, Yacoub M, Froissart R, Miled A, Maire I: Clinico-
biologic and molecular study of mucopolysaccharidosis in central and
southern Tunisia. Ann Biol Clin 2001, 59:100-4.
6. Ben Turkia H, Tebib N, Azzouz H, Abdelmoula MS, Ben Chehida A, Chemli J,
Monastiri K, Chaabouni M, Sanhagi H, Zouari B, Kaabachi N, Ben Dridi MF:
Incidence of mucopolysaccharidoses in Tunisia. Tunis Med 2009,
87:782-785.
7. Nelson J: Incidence of the mucopolysaccharidoses in Northern Irland.
Hum Genet 1997, 101:255-258.
8. Khedhiri S, Chkioua L, Bouzidi H, Dandana A, Ben Turkia H, Miled A,
Laradi S: Mucopolysaccharidoses type I and IVA: Clinical features and
consanguinity in Tunisia. Pathol Biol 2009, 57:392-7.
9. Alif N, Hess K, Straczek J, Sebbar S, N’Bou A, Nabet P, Dousset B:
Mucopolysaccharidosis type I: characterization of a common mutation
that causes Hurler syndrome in Moroccan subjects. Ann Hum Genet 1999,
63:9-16.
10. Laradi S, Tukel T, Erazo M, Shabbeer J, Chkioua L, Khedhiri S, Ferchichi S,
Chaabouni M, Miled A, Desnick RJ: Mucopolysaccharidosis I: Alpha-L-
Iduronidase mutations in three Tunisian families. J Inherit Metab Dis 2005,
28:1019-1026.
11. Chkioua L, Khedhiri S, Kassab A, Bibi A, Ferchichi S, Froissart R, Vianey-
Saban C, Laradi S, Miled A: Molecular analysis of mucopolysaccharidosis
type I in Tunisia: identification of novel mutation and eight Novel
polymorphisms. Diagn Pathol 2011, 6:39.
12. Chkioua L, Khedhiri S, Ben Turkia H, Tcheng R, Ferchichi S, Froissart R,
Francoise Ben Dridi M, Vianey-Saban C, Laradi S, Miled A:
Mucopolysaccharidosis type I: molecular characteristics of two novel
alpha-L-iduronidase in Tunisian patients. Diagn Pathal 2011, 6:47.
13. Al-Gazali LI, Alwash R, Abdulrazzaq YM: United Arab Emirate:Communities
and community genetics. Community Genet 2005, 8:186-196.
14. Hamamy H, Al-Hait S, Alwan A, Ajlouni K: Jordan: Communities and
community genetics. Community Genet 2007, 10:52-60.
15. Scott HS, Litjens T, Nelson PV, Brooks DA, Hopwood JJ, Morris CP: alpha-L-
iduronidase mutations (Q70X and P533R) associate with a severe Hurler
phenotype. Hum Mutat 1992, 1:333-339.
16. Teebi AS, Farag TI, editors: Genetic disorders among Arab populations.
New York: Oxford University Press;, 1 1997.
17. Hoodfar E, Teebi AS: Genetic referrals of Middle-Eastern origin in a
western city: inbreeding and disease profile. J Med Genet 1996, 33:212-5.
18. Alif N, Hess K, Straczek J, Sebbar S, N’Bou A, Nabet P, Dousset B:
Mucopolysaccharidosis type I: characterization of a common mutation
that causes Hurler syndrome in Moroccan subjects. Ann Hum Genet 1999,
63:9-16.
19. Lamdouar Bouazzaoui N: Consanguinity and public health in Morocco.
Bull Acad Natl Med 1994, 178:1013-25.
20. Hussain R, Bittles AH: The prevalence and demographic characteristics of
consanguineous marriages in Pakistan. J Biosoc Sci 1998, 30:261-75.
21. Denic S: Consanguinity as risk factor for cervical carcinoma. Med
Hypotheses 2003, , 60: 321-4.
22. Chkioua L, Ferchichi S, Khedhiri S, Jaidane Z, Chahed H, Wesleti S,
Froissart R, Maire I, Laradi S, Miled A: Prenatal diagnosis of the Hurler
syndrome by microsatellite markers analysis. Immuno-analyse & Biologie
Spécialisé 2010, 38-42.
doi:10.1186/1746-1596-6-113
Cite this article as: Chkioua et al.: Hurler disease (mucopolysaccharidosis
type IH): clinical features and consanguinity in Tunisian population.
Diagnostic Pathology 2011 6:113.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Chkioua et al. Diagnostic Pathology 2011, 6:113
http://www.diagnosticpathology.org/content/6/1/113
Page 7 of 7